Cumulative Cisplatin Dose Is Not Associated With Event-Free or Overall Survival in Children With Newly Diagnosed Average-Risk Medulloblastoma Treated With Cisplatin Based Adjuvant Chemotherapy: Report From the Children's Oncology Group

BACKGROUND: Survival rates for children with medulloblastoma have risen over the past decade, in part due to the addition of cisplatin-containing adjuvant chemotherapy. Total dose of cisplatin required for optimal treatment is unknown. The purpose of this study was to evaluate the survival outcomes...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Pediatr Blood Cancer
Autori principali: Rao, Amulya A. Nageswara, Wallace, Dana J., Billups, Catherine, Boyett, James M., Gajjar, Amar, Packer, Roger J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4591537/
https://ncbi.nlm.nih.gov/pubmed/23956184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.24670
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi